Dutch Version Fear-Avoidance Component Scale (FACS)

NCT ID: NCT03994861

Last Updated: 2023-09-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-08-01

Study Completion Date

2023-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Chronic musculoskeletal disorders such as low back and neck pain are responsible for an enormous global burden. Fear-avoidance (FA) can be a predictor for the transition from subacute to chronic low back pain. In patients with neck pain, those who were less fearful about harming their neck, had higher pain tolerance, which might have a positive impact on their level of disability. A new scale, the Fear-Avoidance Component Scale (FACS) was developed by Neblett, Mayer, Hartzell, Williams and Gatchel (2015) to assess FA. It consists of an all-encompassing set of constructs that more effectively deals with all critical issues of the FA concept than current scales do. Current scales have been criticized because of following findings: limited construct validity, little evidence on treatment responsiveness, a lack of evidence-based cut-off scores and items being too narrow or too general. The new scale comprehensively assesses all cognitive, emotional and behavioral components related to the updated version of the FA model by combining items of well-known scales in context of the FA model with items on one's perception of victimization and blame related to an injury. A Dutch version of the FACS is currently lacking. Subsequently, the aim of this study is to investigate different psychometric properties of the generated Dutch version in patients with musculoskeletal disorders.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Musculoskeletal Pain Musculoskeletal Pain Disorder Fear of Pain Fear of Injury Low Back Pain, Recurrent Neck Pain Shoulder Pain Knee Pain Chronic Hip Pain Chronic PROMs

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Patients with musculoskeletal disorders are compared to matched healthy controls.
Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with musculoskeletal disorders

Patients with either shoulder pain, knee pain, hip pain, low back pain, pelvic pain or neck pain as their primary pain complaint, lasting for 6 weeks or longer

Group Type ACTIVE_COMPARATOR

Assessment of disability and behavior (by questionnaires)

Intervention Type DIAGNOSTIC_TEST

Assessment of disability and behavior (by questionnaires)

Healthy controls

Age- and gender-matched healthy controls (without musculoskeletal pain)

Group Type SHAM_COMPARATOR

Assessment of disability and behavior (by questionnaires)

Intervention Type DIAGNOSTIC_TEST

Assessment of disability and behavior (by questionnaires)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Assessment of disability and behavior (by questionnaires)

Assessment of disability and behavior (by questionnaires)

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* between 18-80 years old
* current pain complaint is not surgically treated
* not being currently treated by a physiotherapist for pain complaint
* Dutch language is mother tongue
* Not being disabled due to MSK pain based on cut-off per disability questionnaire
* Between 18-80 years old
* Dutch language is mother tongue

Exclusion Criteria

* Pain from a non-musculoskeletal origin (e.g., tumour)
* neurological disease
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Jessa Hospital

OTHER

Sponsor Role collaborator

Hasselt University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lotte Janssens

Prof. dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Annick Timmermans, PhD, PT

Role: PRINCIPAL_INVESTIGATOR

Hasselt University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Lotte Janssens

Hasselt, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

18.61/REVA18.02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Kinesiophobia in Chronic Neck Pain
NCT06849999 ACTIVE_NOT_RECRUITING
Prevalence Of Disability And Fear Avoidance Beliefs
NCT07286630 ENROLLING_BY_INVITATION
Muscle Synergies in Pain and Pain Anticipation
NCT07251387 NOT_YET_RECRUITING NA